Venture partners

deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection

April 30, 2025

deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification, announced today the successful closing of an oversubscribed Series C financing round, raising €50 million. The round was co-led by prominent investors Columbus Venture Partners, Panakès Partners, and Mérieux Equity Partners. The financing round also had strong participation from existing investors Asabys Partners, Innvierte-CDTI, We Venture Capital, UI Investissement, Axis-ICO, Aliath Bioventures, and Kurma Partners.

 

Read more